InvestorsHub Logo
icon url

logytwo

03/08/23 10:15 AM

#907 RE: ChuckFinley305 #906

QSAM Biosciences Receives Clearance from FDA to Expand Enrollment Criteria in its Phase 1 Study of CycloSam® Targeting Metastatic Bone Cancer